STERIS plc (STE) is a publicly traded Healthcare sector company. As of May 20, 2026, STE trades at $216.65 with a market cap of $20.88B and a P/E ratio of 29.98. STE moved +0.49% today. Year to date, STE is -15.88%; over the trailing twelve months it is -13.77%. Its 52-week range spans $195.14 to $269.44. Analyst consensus is buy with an average price target of $284.50. Rallies surfaces STE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Steris Q4 EPS $2.83 and $1.59B Revenue Miss Estimates; Shares Dip: STERIS reported Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both narrowly missing consensus estimates. Shares dipped in after-hours trading despite management’s optimistic outlook for fiscal 2027.
| Metric | Value |
|---|---|
| Price | $216.65 |
| Market Cap | $20.88B |
| P/E Ratio | 29.98 |
| EPS | $7.20 |
| Dividend Yield | 0.63% |
| 52-Week High | $269.44 |
| 52-Week Low | $195.14 |
| Volume | 682.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.83B |
| Net Income | $710.77M |
| Gross Margin | 44.11% |
3 analysts cover STE: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $284.50.